Axplora

Paris, France
Small Molecule API Intermediates High-Potency APIs Custom Synthesis
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (5) ○ Clinical Trials ○ SEC Filings ✓ Press (11) ○ EMA GMP ○ MHRA GMP ✓ HC GMP (25)

Quick Facts: Axplora

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Paris, France
Website
Modalities
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Active Programs
No ClinicalTrials.gov matches confirmed — 1 partnership signal in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Axplora

Axplora is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis. 8 manufacturing sites registered with the U.S. FDA and Health Canada, including Farmabios in Gropello Cairoli, Italy. Website: https://www.axplora.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Axplora FDA Inspection History

2025-05
2025-02
2025-02
2023-11
2022-06
NAI VAI OAI
Date Site Type Observations Classification
2025-05-09
Pharmazell (India) Private Limited
Chennai Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2025-02-27
Finorga SAS
Chasse Sur Rhone Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2025-02-07
Pharmazell (India) Private Ltd
Visakhapatnam Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-11-24
Finorga
Mourenx Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2022-06-30
PharmaZell GmbH
Raubling Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 11 articles

Company announcements, not verified evidence. They do not change any score.
news Wed, 12 Fe
Axplora Group announces €50m expansion of GLP-1 manufacturing site - European Biotechnology Magazine
news Tue, 17 Ma
Axplora Expands Farmabios Site in Gropello Cairoli - Contract Pharma
news Thu, 19 Ma
CDMO Axplora to pump $60M into Italian complex API plant - Fierce Pharma
news Thu, 13 Fe
CDMO Axplora reveals €50M expansion at French production site - Fierce Pharma
news Thu, 13 Fe
CDMO Axplora bets €50M on ADC and GLP-1 growth - BioProcess International
news Thu, 11 Ju
Axplora Repositions European Site on High-Potency Drugs as India Takes Over UDCA Production - CHEManager
news Thu, 03 Ap
Axplora Adding New Facility for Purification of Peptides, Other APIs - DCAT Value Chain Insights
news Mon, 23 Fe
Axplora expands Le Mans manufacturing site to support increased ADC demand - BioProcess International
news Mon, 07 Ju
Axplora To Double Its Manufacturing Capacity In Italy With Expansion - Pharmaceutical Online
news Mon, 02 Ma
Major Announcements for Axplora - The Medicine Maker
partnership 2026-10-27
Abionyx Pharma Partners with Axplora and Completes CER-001 Production Chain - Idéal Investisseur
Abionyx Pharma Partners with Axplora and Completes CER-001 Production Chain  Idéal Investisseur

Frequently Asked Questions About Axplora

How many FDA inspections does Axplora have on record?
CDMO Signal tracks 5 FDA inspections for Axplora, sourced from the FDA inspection database. See the full inspection history above.
Has Axplora received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Axplora.
Does Axplora have a CDMO Signal Score?
Not yet. Axplora is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Axplora for a manufacturing program?
Use the free AI matchmaker to compare Axplora against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Zhejiang Tianyu Pharmaceutical
Taizhou, Zhejiang, China
Small Molecule API, Intermediates, Custom Synthesis, High-Potency APIs, Spray Drying
Yuhan Chemical
Ansan, Gyeonggi-do, South Korea
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
ICROM
Concorezzo (MB), Italy
Small Molecule API, Intermediates, Custom Synthesis
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Lianhetech Seal Sands (Fine Organics Limited)
Middlesbrough, United Kingdom
Small Molecule API, Intermediates, Custom Synthesis

Compare Axplora with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Axplora
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.